CD274 and glioma: For instance, Bassoyet al. have demonstrated that blockade of inhibitory PD-1/B7H1 pathway promoted NK cells mediated killings of glioma stem cells, and thus suggested that PD-1 inhibition could be a feasible immune therapeutic approach against glioma [18].